GGrantIndex
Sort

23,748 grants matching melanoma

Coordinating tumor differentiation and immune suppression with the metabolic state and treatment outcome

$341,157
Hans Ragnar Widlund · Brigham And Women'S Hospital · R01 · FY2022 · CA

Stinging the Glioma Immune Landscape

$341,138
Amy Beth Heimberger · Northwestern University At Chicago · R01 · FY2022 · NS

Molecular Analysis of CD8, MHC Class I Interaction

$341,137
Paula B. Kavathas · Yale University · R01 · FY2011 · CA

Molecular Analysis of CD8, MHC Class I Interaction

$341,137
Paula B. Kavathas · Yale University · R01 · FY2012 · CA

Targeting HSP70 in autoimmune vitiligo

$341,128
Isabelle Caroline Le Poole · Loyola University Chicago · R01 · FY2008 · AR

Multi-Antigen Vaccines for Breast Cancer

$341,100
University Of Washington · R01 · FY2003 · CA

Multi-Antigen Vaccines for Breast Cancer

$341,100
University Of Washington · R01 · FY2005 · CA

Multi-Antigen Vaccines for Breast Cancer

$341,100
University Of Washington · R01 · FY2004 · CA

Retargeting of Retroviral Vectors

$341,020
Irvin S.y. Chen · University Of California Los Angeles · R01 · FY2008 · AI

Retargeting of Retroviral Vectors

$341,020
Irvin S.y. Chen · University Of California Los Angeles · R01 · FY2009 · AI

Identification of Druggable Targets to Complement Melanoma Therapy

$340,960
Alan Jackson Tackett · Univ Of Arkansas For Med Scis · R01 · FY2022 · CA

Identification of Druggable Targets to Complement Melanoma Therapy

$340,960
Alan Jackson Tackett · Univ Of Arkansas For Med Scis · R01 · FY2023 · CA

Optimization of Autophagy Inhibition as a Clinical Target for Brain Tumors

$340,927
Jean Marie Mulcahy Levy · University Of Colorado Denver · R01 · FY2022 · NS

Mechanisms of photocarcinogenesis in geriatric skin

$340,920
Dan F Spandau · Indiana University Indianapolis · R01 · FY2012 · ES

Molecularly Engineered Constructs for anti-CD20 Directed Therapeutics

$340,858
Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P50 · FY2008 · CA

Identifying a nodal point for G alpha q signaling in eye disease

$340,838
Shannon J Odelberg · University Of Utah · R01 · FY2020 · CA

Identifying a nodal point for G alpha q signaling in eye disease

$340,838
Shannon J Odelberg · University Of Utah · R01 · FY2018 · CA

Identifying a nodal point for G alpha q signaling in eye disease

$340,838
Dean Yaw Li · University Of Utah · R01 · FY2016 · CA

Identifying a nodal point for G alpha q signaling in eye disease

$340,838
Shannon J Odelberg · University Of Utah · R01 · FY2017 · CA

Biomaterials-based metabolic rescue of dendritic cells for vaccine design

$340,828
Abhinav Acharya · Arizona State University-Tempe Campus · R01 · FY2021 · AI

Biomarkers and Resistance Mechanisms in Melanoma T-cell Therapy

$340,821
Patrick Hwu · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA

Biomarkers and Resistance Mechanisms in Melanoma T-cell Therapy

$340,821
Patrick Hwu · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA

Ipilimumab as an adjuvant for HIV vaccines

$340,800
Mauricio De Aguiar Martins · University Of Miami School Of Medicine · K01 · FY2016 · OD

Identifying and targeting evolutionary trajectories in cancer

$340,788
Michael Hemann · Massachusetts Institute Of Technology · R01 · FY2020 · CA

Novel anti-oxidant catalyst to treat IL-2 toxicity

$340,727
Inotek Pharmaceuticals Corporation · R43 · FY2003 · CA